Fig. 6

Typical chromatograms of co-formulated tablet of the studied drugs VPS (10 ng/mL) and SFV (40 ng/mL) under the described chromatographic conditions (Method 2A and B). a Method 2 utilizing column A. b Method 2 utilizing column B
Typical chromatograms of co-formulated tablet of the studied drugs VPS (10 ng/mL) and SFV (40 ng/mL) under the described chromatographic conditions (Method 2A and B). a Method 2 utilizing column A. b Method 2 utilizing column B